In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous Drugs
Open Access
- 1 January 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (1) , 416-417
- https://doi.org/10.1128/aac.47.1.416-417.2003
Abstract
We evaluated 117 isolates of Mycobacterium tuberculosis for susceptibility to linezolid by the proportion and E-test methods. Linezolid showed high in vitro activity, with all the strains inhibited by ≤1 μg of the drug per ml. E-test MICs were at least 4 dilutions lower than their equivalents by the standard proportion method.Keywords
This publication has 9 references indexed in Scilit:
- Antituberculosis drugs and new drug developmentCurrent Opinion in Pulmonary Medicine, 2001
- In vitro activity of linezolid against multiply resistant Gram-positive clinical isolatesJournal of Antimicrobial Chemotherapy, 2001
- [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].2001
- Global Burden of TuberculosisJAMA, 1999
- Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine ModelAntimicrobial Agents and Chemotherapy, 1999
- Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactionsAntimicrobial Agents and Chemotherapy, 1997
- In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsAntimicrobial Agents and Chemotherapy, 1996
- In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinonesAntimicrobial Agents and Chemotherapy, 1996